General description
Intended use
The EHY-2000plus device is intended for the adjuvant treatment of deep-
seated primer and metastasized solid malignant tumors in combination regimen
with chemotherapy and/or radiation therapy. The performance of the EHY-
2000plus device is supported with clinical evidences in the following indications:
▪ Glioblastoma,
▪ Esophageal cancer,
▪ Gastric cancer,
▪ Liver cancer,
▪ Cancer of kidney and renal pelvis,
▪ Cervical cancer,
▪ Pancreatic cancer,
▪ Breast cancer,
▪ Lung cancer.
The performance of the EHY-2000plus device is also supported with clinical
experience in the following indications:
▪ Bladder cancer,
▪ Prostate cancer,
▪ Colorectal cancer,
The collection of additional clinical data to establish clinical evidence
concerning the performance of the EHY-2000plus device in the latter indications
is in progress.
Target group
Patients who suffer from solid malignant tumors with age over 6 years.
To Next Page
Loading...